PUREGON® 300 IU (Follitropin Beta) – Product Description

PUREGON® 300 IU contains Follitropin Beta, a recombinant human follicle-stimulating hormone (rFSH) used in assisted reproductive technologies and fertility treatment. It is supplied as a solution for injection in a pre-filled pen for subcutaneous administration.

Composition

• Active ingredient: Follitropin Beta
• Strength: 300 IU per cartridge/pen
• Pharmaceutical form: Solution for injection
• Administration route: Subcutaneous injection

Package Contents

• 1 pre-filled PUREGON Pen cartridge containing 300 IU Follitropin Beta
• Sterile injection needles (quantity may vary by market)
• Patient information leaflet

Indications

PUREGON is commonly prescribed for:

• Controlled ovarian stimulation in women undergoing assisted reproduction techniques such as IVF
• Induction of ovulation in women with ovulatory disorders
• Stimulation of sperm production in selected men with hypogonadotropic hypogonadism, usually in combination with hCG

Features

• Recombinant FSH produced using advanced biotechnology
• Precise dose administration using the PUREGON Pen
• Ready-to-use solution requiring no reconstitution
• Designed for self-administration following appropriate training

Storage

• Store in a refrigerator at 2°C–8°C
• Do not freeze
• Keep in the original package to protect from light
• Follow manufacturer instructions regarding storage after first use

Packaging

• Product: PUREGON®
• Active Substance: Follitropin Beta
• Strength: 300 IU
• Presentation: Pre-filled pen/cartridge for injection
• Quantity: 1 pen/cartridge

Note: PUREGON is a prescription fertility medication and should be used only under the supervision of a qualified healthcare professional experienced in reproductive medicine.